3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Lung Neoplasms
4
Glioblastoma
3
Urinary Bladder Neoplasms
2
Glioma
2
Brain Neoplasms
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Tuberculosis, Pulmonary
1
Thyroid Nodule
1
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Pulmonary Fibrosis
1
Pulmonary Embolism
1
Pulmonary Disease, Chronic Obstructive
1
Pulmonary Arterial Hypertension
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Pulmonary Nodules
1
Mesothelioma
1
Lung Injury
1
Lung Diseases, Interstitial
1
Lung Diseases
1
Lung Abscess
1
Esophageal Neoplasms
1
Emphysema
1
Disease
1
Cystic Fibrosis
1
Colorectal Neoplasms
1
Interventions
Capecitabine
77
pembrolizumab
70
Oxaliplatin
68
Cisplatin
56
Fluorouracil
52
Paclitaxel
41
Trastuzumab
37
Nivolumab
35
Leucovorin
27
Docetaxel
27
Irinotecan
22
Ramucirumab
20
Gemcitabine
15
Bevacizumab
15
S 1 (combination)
14
Carboplatin
13
atezolizumab
12
apatinib
12
fludarabine
11
Cyclophosphamide
11
tislelizumab
10
Drug Therapy
10
Injections
8
130-nm albumin-bound paclitaxel
8
trastuzumab deruxtecan
7
durvalumab
7
Ipilimumab
7
Folfox protocol
7
Albumin-Bound Paclitaxel
7
titanium silicide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Stomach Neoplasms
×
Drug Delivery Systems
×
Clear all
NCT05899985
2026-04-06
MAGMAP
Ferronova Pty Ltd
Phase NA
Active not recruiting
60 enrolled